97 related articles for article (PubMed ID: 17251905)
21. Antibodies and immunohistochemical evaluation for the diagnosis of hematological malignancies: an overview.
O'Malley DP; Orazi A
Methods Mol Biol; 2007; 378():91-123. PubMed ID: 18605081
[TBL] [Abstract][Full Text] [Related]
22. Philadelphia chromosome-negative chronic myeloproliferative disease.
Thiele J
Am J Clin Pathol; 2009 Aug; 132(2):261-80. PubMed ID: 19605821
[TBL] [Abstract][Full Text] [Related]
23. An integrated approach to mapping the proteome of the human bone marrow stromal cell.
Seshi B
Proteomics; 2006 Oct; 6(19):5169-82. PubMed ID: 16947122
[TBL] [Abstract][Full Text] [Related]
24. [A differential analysis of development of bone marrow erythroclastic clusters in hemopoietic disorders].
Bel'chenko DI; Krivosheina EL; Khanina NIa; Volkova OV; Smirnova EA; Rekhtina IG
Patol Fiziol Eksp Ter; 2008; (4):25-6. PubMed ID: 19202618
[No Abstract] [Full Text] [Related]
25. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
26. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
27. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
Kreipe HH
Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
[TBL] [Abstract][Full Text] [Related]
28. Characterization of murine JAK2V617F-positive myeloproliferative disease.
Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
[TBL] [Abstract][Full Text] [Related]
29. In vitro growth of hematopoietic progenitors and stromal bone marrow cells from patients with multiple myeloma.
Martínez-Jaramillo G; Vela-Ojeda J; Flores-Guzmán P; Mayani H
Leuk Res; 2011 Feb; 35(2):250-5. PubMed ID: 20621354
[TBL] [Abstract][Full Text] [Related]
30. Indications and diagnostic utility of bone marrow examination in different bone marrow disorders in Iran.
Mirzai AZ; Hosseini N; Sadeghipour A
Lab Hematol; 2009; 15(4):38-44. PubMed ID: 19923104
[TBL] [Abstract][Full Text] [Related]
31. Different lineage involvement in myelodysplastic/myeloproliferative disease with combined MPLW515L and JAK2V617F mutation.
Hussein K; Theophile K; Buhr T; Beller A; Kreipe H; Bock O
Br J Haematol; 2009 Jun; 145(5):673-5. PubMed ID: 19344408
[No Abstract] [Full Text] [Related]
32. Defective stromal cell function in a mouse model of infusion-induced bone marrow failure.
Chen J; Brandt JS; Ellison FM; Calado RT; Young NS
Exp Hematol; 2005 Aug; 33(8):901-8. PubMed ID: 16038782
[TBL] [Abstract][Full Text] [Related]
33. [Histomorphologic findings of the bone marrow in chronic myeloproliferative diseases].
Thiele J; Fischer R
Z Hautkr; 1989 Oct; 64(10):903-4, 909-12. PubMed ID: 2686247
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders.
Bock O; Schlué J; Kreipe H
Leukemia; 2003 Apr; 17(4):815-6. PubMed ID: 12682647
[No Abstract] [Full Text] [Related]
35. Critical features of FAK-expressing AML bone marrow microenvironment through leukemia stem cell hijacking of mesenchymal stromal cells.
Despeaux M; Labat E; Gadelorge M; Prade N; Bertrand J; Demur C; Recher C; Bonnevialle P; Payrastre B; Bourin P; Racaud-Sultan C
Leukemia; 2011 Nov; 25(11):1789-93. PubMed ID: 21647157
[No Abstract] [Full Text] [Related]
36. Aberrant proplatelet formation in chronic myeloproliferative neoplasms.
Muth M; Büsche G; Bock O; Hussein K; Kreipe H
Leuk Res; 2010 Nov; 34(11):1424-9. PubMed ID: 20430444
[TBL] [Abstract][Full Text] [Related]
37. Immunofluorescence and confocal laser scanning microscopy of chronic myeloproliferative disorders on archival formaldehyde-fixed bone marrow.
Suetterlin R; Baschong W; Laeng RH
J Histochem Cytochem; 2004 Mar; 52(3):347-54. PubMed ID: 14966201
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
39. [Two cases of unclassified chronic myeloproliferative disorders].
Hirano A; Takahashi I; Haruta Y; Nakamura T; Nakata H; Yorimitsu S; Sekito N; Kimura I
Rinsho Ketsueki; 1992 Apr; 33(4):525-31. PubMed ID: 1602619
[TBL] [Abstract][Full Text] [Related]
40. Granulopoiesis in chronic myeloproliferative disorders in children.
Crist WM; Ragab A; Moreno H; Pereira F; Foster JC
Pediatrics; 1978 Jun; 61(6):889-93. PubMed ID: 276837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
